Stepping Up? Pharma’s Early COVID Pricing Decisions May Be Resolving Concerns
Cigna's Steve Miller suggests pharma is taking a responsible approach to pricing during the pandemic in a policy discussion convened by the Institute for Clinical and Economic Review on pricing models for COVID-19 drugs and vaccines.